<sentence id="0">Selective activation of apoptosis by a novel set of 4-aryl-3-(3-aryl-1-oxo-2-propenyl)-2(1H)-quinolinones through a Myc-dependent pathway .</sentence>
<sentence id="1">Oncogene addiction due to Myc deregulation has been identified in a variety of tumor types .</sentence>
<sentence id="2">In order to identify pharmacological agents that cause selective apoptosis in tumors with deregulated Myc expression , we designed a cell-based screening assay based on our Anti-cancer Screening Apoptosis Program ( ASAP ) technology targeting increased activity in a " Myc-addicted " cancer cell panel .</sentence>
<sentence id="3">We have identified a novel set of substituted 4-aryl-3-(3-aryl-1-oxo-2-propenyl)-2(1H)-quinolinones that activates apoptosis in cancer cell lines with deregulated Myc , but show low activity in cell lines where <scope type="neg" id="0">Myc is <cue type="neg" id="0">not</cue> deregulated</scope> .</sentence>
<sentence id="4">Apoptosis induced by these compounds is rapid , and is associated with a significant downregulation of Myc protein .</sentence>
<sentence id="5">Selective knockdown of Myc levels in these cells by RNA interference increased sensitivity to apoptosis with compound treatment .</sentence>
<sentence id="6">By targeting the Myc pathway in Myc-addicted cancer cells , we have identified a novel class of apoptotic inducers that selectively and efficiently target cancer cells with deregulated Myc .</sentence>